CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
0.6158
-0.0042 (-0.68%)
At close: Feb 20, 2026, 4:00 PM EST
0.6200
+0.0042 (0.68%)
After-hours: Feb 20, 2026, 6:14 PM EST
CollPlant Biotechnologies Market Cap
CollPlant Biotechnologies has a market cap or net worth of $8.87 million as of February 20, 2026. Its market cap has decreased by -79.37% in one year.
Market Cap
8.87M
Enterprise Value
3.26M
1-Year Change
-79.37%
Ranking
Category
Stock Price
$0.62
Market Cap Chart
Since January 31, 2018, CollPlant Biotechnologies's market cap has decreased from $30.60M to $8.87M, a decrease of -71.02%. That is a compound annual growth rate of -14.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 7.10M | -55.63% |
| Dec 31, 2025 | 16.00M | -61.17% |
| Dec 31, 2024 | 41.20M | -43.72% |
| Dec 29, 2023 | 73.20M | -20.95% |
| Dec 30, 2022 | 92.60M | -47.06% |
| Dec 31, 2021 | 174.90M | 147.03% |
| Dec 31, 2020 | 70.80M | 226.27% |
| Dec 31, 2019 | 21.70M | 55.00% |
| Dec 31, 2018 | 14.00M | -54.25% |
| Jan 31, 2018 | 30.60M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bolt Biotherapeutics | 9.69M |
| Chemomab Therapeutics | 9.66M |
| BioVie | 9.50M |
| TransCode Therapeutics | 8.89M |
| SeaStar Medical Holding | 8.80M |
| NuCana | 8.74M |
| GridAI Technologies | 8.67M |
| Quince Therapeutics | 8.36M |